David Crispino Volpe, Chief Financial Officer at AdvanSource Biomaterials Corp (ASNB), bought 20,000 shares at $0.05 ($1K) on 2013-12-03, disclosed to the SEC on 2013-12-06.
Open-market purchase of $1k ASNB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.05 | 2,000 | $100 | 10.0% |
| 2 | $0.05 | 8,000 | $400 | 40.0% |
| 3 | $0.05 | 10,000 | $500 | 50.0% |
| Total | $0.05 avg | 20,000 | $1K | 100% |
| Filing → |
| ASNB | BUY | 2012-12-04 | $150 | — | Filing → |
| ASNB | BUY | 2012-12-03 | $200 | — | Filing → |
| ASNB | BUY | 2012-11-21 | $1K | — | Filing → |